about
Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interactionHost sequence motifs shared by HIV predict response to antiretroviral therapyDevelopment of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia.Invariant NKT cells: regulation and function during viral infection.Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infectionImpairment of CD1d-restricted natural killer T cells in chronic HIV type 1 clade C infection.Retinoic acid and α-galactosylceramide differentially regulate B cell activation in vitro and augment antibody production in vivoHIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDSHiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activationDifferential loss of invariant natural killer T cells and FoxP3⁺ regulatory T cells in HIV-1 subtype A and subtype D infections.Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders.Cytometry, immunology, and HIV infection: three decades of strong interactions.Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy.Defining the roles for Vpr in HIV-1-associated neuropathogenesis.Invariant natural killer T cells: front line fighters in the war against pathogenic microbes.HIV infection: focus on the innate immune cells.Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.A single amino acid defines cross-species reactivity of tree shrew (Tupaia belangeri) CD1d to human invariant natural killer T (iNKT) cells.Preferential depletion of gut CD4-expressing iNKT cells contributes to systemic immune activation in HIV-1 infectionCD4(+) and CD4(-) CD1D-restricted natural killer T cells in perinatally HIV-1 infected children receiving highly active antiretroviral therapy.Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiency.
P2860
Q24313634-CE057287-268B-42B9-A7A7-0BE98259D6C7Q33486144-27D77A48-295E-4853-8693-29B7B288FEDAQ34235221-902A3B9B-E5CB-4F98-A4DB-960FEA0424C8Q34390484-CA8ED365-7F41-41D1-9837-4B68D0DA3DD9Q34426479-BE490D12-A794-46FC-8AD0-0C587C08D871Q34875335-C76CDCA6-5C3D-4D06-B018-9220CE4D7140Q35066481-257333B1-B812-424B-8CA5-EB0D2552F004Q35585948-0E00A5C1-072A-490E-A6FD-0741AF4F52F4Q36395876-E4CFFB5E-DD1E-4D92-A615-11D14DBDAD03Q36930427-A639B6D1-A9DC-4DE7-B150-DCFAB0A02A5DQ37381691-F1AE2C59-FE04-41D0-90A8-0F5253A899CEQ38115992-C5746D09-F60F-427A-845D-0970718C68CDQ38255412-19D52FEA-E407-419F-BC1E-AAB86E5BC06BQ38801550-E5FF290C-1929-42F6-A39E-1272F472B828Q38883497-43F18555-2F6C-4488-BF3D-7E4EA10EC9E0Q38945041-CBA3B31E-192B-4EBB-A308-B41A6C93433FQ39297216-41ACAD18-FE73-47D1-8F64-2AC15C5D8CF5Q39934759-9134EF81-FEC2-49E1-B1F9-2A5D9B518E32Q42258972-05CCDEA5-2CE3-4778-ABF9-FF9FE9727129Q45150866-F6C96965-BDBC-477D-BAA1-03A34A63B98FQ51891238-52DE34CE-D3C7-4199-853C-A3C72F4A5B2B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NKT cells in HIV-1 infection.
@en
NKT cells in HIV-1 infection.
@nl
type
label
NKT cells in HIV-1 infection.
@en
NKT cells in HIV-1 infection.
@nl
prefLabel
NKT cells in HIV-1 infection.
@en
NKT cells in HIV-1 infection.
@nl
P2860
P356
P1433
P1476
NKT cells in HIV-1 infection.
@en
P2093
Xiao-Ning Xu
P2860
P2888
P304
P356
10.1038/CR.2008.85
P50
P577
2008-08-01T00:00:00Z